ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference
ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 11, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for treatment of prostate cancer, today announced that the Company will be presenting at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, at 9:10 a.m. ET in New York, NY.
加利福尼亚州南旧金山和不列颠哥伦比亚省温哥华，2024年9月11日 /PRNewswire/-专注于开发前列腺癌治疗新疗法的临床阶段制药公司ESSA Pharma Inc.（“ESSA” 或 “公司”）（纳斯达克股票代码：EPIX）今天宣布，该公司将在美国东部时间2024年9月18日星期三上午9点10分在纽约举行的2024年Cantor全球医疗保健会议上发表演讲，纽约。
David R. Parkinson, President and Chief Executive Officer, Peter Virsik, Chief Operating Officer and Executive Vice President, and David S. Wood, Chief Financial Officer, will participate in a fireside chat.
总裁兼首席执行官大卫·帕金森、首席运营官兼执行副总裁彼得·维尔西克和首席财务官戴维·伍德将参加炉边谈话。
A live webcast of the fireside chat can be accessed in the Investors/Events & Presentations section of ESSA's website at . Following the event, the webcast will be archived on the ESSA website for 90 days.
可以在ESSA网站的 “投资者/活动与演示” 部分观看炉边谈话的网络直播，网址为。活动结束后，网络直播将在ESSA网站上存档90天。
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit , and follow us on X and LinkedIn.
关于 ESSA Pharma Inc
ESSA是一家临床阶段的制药公司，专注于开发用于治疗前列腺癌患者的新型专有疗法。欲了解更多信息，请访问并在 X 和 LinkedIn 上关注我们。
Contacts
ESSA Pharma Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
[email protected]
联系人
ESSA 制药公司
彼得·维尔西克，首席运营官
778.331.0962
[电子邮件保护]
Investors and Media:
Argot Partners
212.600.1902
[email protected]
投资者和媒体：
Argot Par
212.600.1902
[电子邮件保护]
SOURCE ESSA Pharma Inc
来源 ESSA Pharma
